茵蔯, 鬱金, 枳實 추출물(ACA)이 HepG2 세포에서 나타나는 이상지질혈증 관련 인자 발현 및 항산화에 미치는 영향
The Effects of Artemisiae Iwayomogii Herba, Curcumae Radix, and Aurantii Fructus Immaturus Complex Extract (ACA) on Dyslipidemia-related Factor Expression and Anti-oxidation in HepG2 Cells
2
조회
0
다운로드
5
인용
0
참고문헌
키워드
초록
Objective: To investigate the effect of Artemisiae Iwayomogii Herba, Curcumae Radix, and Aurantii Fructus Immaturus complex extract (ACA) on dyslipidemia-related factor expression and anti-oxidation in HepG2 cells. Method: After treatment with ACA in the HepG2 cells, DPPH, ABTS radical scavenging activity, ROS production, and glutathione (GSH) production were measured. The free fatty acid, lipid peroxidation (MDA), ACAT1, and HMG-CoA reductase mRNA expression were measured in the HepG2 cells after treatment with ACA. Results: 1. DPPH, ABTS radical scavenging activity increased in an ACA concentration-dependent manner. 2. ACA significantly decreased ROS production in comparison to the control group. 3. ACA significantly increased glutathione production. 4. ACA significantly decreased free fatty acid and lipid peroxidation (MDA) in the HepG2 cells. 5. ACA decreased the mRNA expression of ACAT1 and HMG-CoA reductase. Conclusion: These results suggest that Artemisiae Iwayomogii Herba, Curcumae Radix, and Aurantii Fructus Immaturus complex extract (ACA) inhibits dyslipidemia-related factor expression and that it is effective in anti-oxidation. A future in vivo experiment with ACA is needed to investigate the effect on anti-dyslipidemia. It is expected that ACA is effective in anti-dyslipidemia and applied to cardiovascular disease, ischemic heart disease, stroke, etc.
Abstract
Objective: To investigate the effect of Artemisiae Iwayomogii Herba, Curcumae Radix, and Aurantii Fructus Immaturus complex extract (ACA) on dyslipidemia-related factor expression and anti-oxidation in HepG2 cells. Method: After treatment with ACA in the HepG2 cells, DPPH, ABTS radical scavenging activity, ROS production, and glutathione (GSH) production were measured. The free fatty acid, lipid peroxidation (MDA), ACAT1, and HMG-CoA reductase mRNA expression were measured in the HepG2 cells after treatment with ACA. Results: 1. DPPH, ABTS radical scavenging activity increased in an ACA concentration-dependent manner. 2. ACA significantly decreased ROS production in comparison to the control group. 3. ACA significantly increased glutathione production. 4. ACA significantly decreased free fatty acid and lipid peroxidation (MDA) in the HepG2 cells. 5. ACA decreased the mRNA expression of ACAT1 and HMG-CoA reductase. Conclusion: These results suggest that Artemisiae Iwayomogii Herba, Curcumae Radix, and Aurantii Fructus Immaturus complex extract (ACA) inhibits dyslipidemia-related factor expression and that it is effective in anti-oxidation. A future in vivo experiment with ACA is needed to investigate the effect on anti-dyslipidemia. It is expected that ACA is effective in anti-dyslipidemia and applied to cardiovascular disease, ischemic heart disease, stroke, etc.
참고문헌 (26)
- World Health Organization(CH), "Global Health Observatory(GHO) data. Deaths from NCDs" (2012), World Health Organization
- Committee for Guidelines for Management of Dyslipidemia, "2015 Korean Guidelines for Management of Dyslipidemia", J Lipid Atheroscler, 4(1), pp.61~92 (2015)
- Jang US, "Lipid-lowering and Antioxidant Effect of Artemisia capillaris in Poloxamer-407 induced Hyperlipidemia Model in Rat", Doctor, pp.2011
- 박소애, "Lipid-lowering and Antioxidant Effects of Curcuma Radix in Poloxamer 407-induced Hyperlipidemia Model Rat Models", 대한한방내과학회지, 32(2), pp.243~258 (2011), 대한한방내과학회
- 최호영, "국산과 중국산 枳實의 Triton WR-1339 유발 高脂血症 흰쥐에 대한 효능 연구", 대한본초학회지, 22(3), pp.109~116 (2007), 대한본초학회
- Kim YD, "A study of the effects of Gualouzhishitang and Gualouzhishitangjiawei on hyperlipidemia", Master, pp.1993
- 안가영, "고지방 식이로 유발된 고지혈증 동물 모델에서 枸杞子加味方의 효과 연구", 대한한방내과학회지, 35(4), pp.505~518 (2014), 대한한방내과학회
- 박치영, "HK-1000 약침이 흰쥐의 고지혈증 및 동맥경화증에 미치는 영향", Journal of Pharmacopuncture, 11(3), pp.55~66 (2008), 대한약침학회
- Lee SJ, "ACE Reduces Metabolic Abnormalities in a High-Fat Diet Mouse Model", Evid Based Complement Alternat Med, 2015, pp.1~8 (2015)
- 김현태, "db", db mouse에서 茵蔯, 鬱金, 山査 복합추출물의 항고지혈 및 항산화 효과, 2016, pp.37(3), 467~483[DOI]
- 최고은, "제2형 당뇨 마우스 모델에서 청혈플러스의 항고지혈 및 항산화효과", 동의생리병리학회지, 30(3), pp.164~176 (2016), 한의병리학회[DOI]
- 김병목, "HepG2 cell에서 식용수산자원 추출물의 지질축적억제효과", 한국식품과학회지, 44(3), pp.362~366 (2012), 한국식품과학회
- Ministry of Health and Welfare, "Korea National Health and Nutrition Examination Survey, 3rd Year of the Sixth Period(2015)", pp.24~ (2016), Korea Centers for Disease Control and Prevention
- Kim JC, "SIM Integral medicine. Part Ⅲ; Cardiology", pp.205~208 (2013), Jungdam
- Yang YG, "Interpretation of Huang Di Nei Jing(Yellow Emperor’s Inner Canon) Yeongchu", pp.296~297 (1991), Iljungsa
- Bang HJ, "Korean medicine approach to hyperlipidemia", J of East-west Medicines, 20(1), pp.25~36 (1995)
- Association Textbook Publish Committee of National Oriental Medical Department, "Herbal medicine", pp.369~ (2010), Younglimsa
- 김민선, "울금(Curcuma longa L.)이 고지방․고콜레스테롤 식이 흰쥐의 항산화계 및 산화적 손상에 미치는 영향", 한국식품영양과학회지, 42(4), pp.570~576 (2013), 한국식품영양과학회
- 손명수, "3T3-L1 세포에서 울금(Curcuma longa L.) 추출물의 항비만 및 항산화 활성", 아시안뷰티화장품학술지, 12(2), pp.169~175 (2014), 한국피부과학연구원
- Yang RL, "Increasing Oxidative Stress with Progressive Hyperlipidemia in Human: Relation between Malondialdehyde and Atherogenic Index", J of clinical biochemistry and nutrition, 43(3), pp.154~ (2008)
- Wang SR, "Lipied and lipoprotein metabolism in Hep G2 cells", Biochi Biophy Acat, 961, pp.351~363 (1988)
- 김민정, "In Vitro 항산화능 측정법에 대한 특징 분석과 채소․과일 시료에 대한 적용 사례 고찰", 한국식품영양과학회지, 40(7), pp.1053~1062 (2011), 한국식품영양과학회
- Meister A, "Glutathione", Annu Rev Biochem, 52, pp.711~760 (1983)
- Kim DH, "The Relation of Aging, Chronic Degenerative Disease, and Lipid Peroxides", J of Exercise Nutrition & Biochemistry, 4(2), pp.63~71 (2000)
- Vaziri ND, "Up-regulation of acylcoenzyme A:cholesterol acyltransferase(ACAT) in nephrotic syndrome", Kidney Int, 61(5), pp.1769~1775 (2002)
- Liang K, "HMG-CoA reductase inhibition reverses LCAT and LDL receptor deficiencies and improves HDL in rats with chronic renal failure", Am J Physiol Renal Physiol, 288(3), pp.539~544 (2005)